SuperworthSkye Bioscience shares outstanding SKYE
Diluted shares outstanding, averaged over each quarter, from 2012.
- Latest quarter, to Jun 30, 2026
- 5M
- On a year earlier
- +0.1%
- more shares
Skye Bioscience had 5M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is about the same as a year earlier.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 5M | −1% |
| FY2024 | 5M | +224% |
| FY2023 | 1.5M | +322% |
| FY2022 | 365.7K | +48% |
| FY2021 | 247.9K | +65% |
| FY2020 | 149.9K | +71% |
| FY2019 | 87.6K | +32% |
| FY2018 | 66.1K | +335% |
| FY2017 | 15.2K | +89% |
| FY2016 | 8K | −12% |
| FY2015 | 9.1K | +24% |
| FY2014 | 7.4K | +357% |
| FY2013 | 1.6K | −59% |
| FY2013 | 3.9K | +230% |
| FY2012 | 1.2K | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 5M | +0% | |
| Q1 FY26 | 5M | +0% | |
| Q4 FY25 | 5M | −1% | |
| Q3 FY25 | 5M | +2% | |
| Q2 FY25 | 5M | +3% | |
| Q1 FY25 | 5M | +42% | |
| Q4 FY24 | 5M | +224% | |
| Q3 FY24 | 4.9M | +393% | |
| Q2 FY24 | 4.8M | +895% | |
| Q1 FY24 | 3.5M | +643% | |
| Q4 FY23 | 1.5M | +322% | |
| Q3 FY23 | 985.1K | +297% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Skye Bioscience
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.